Cubist Systematic Strategies, LLC Argenx Se Transaction History

Cubist Systematic Strategies, LLC

$15.8 Billion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$334.23 - $403.65 $3.16 Million - $3.81 Million	-9,441 Reduced 80.47%	2,292 $853,000
Q4 2022 Feb 14, 2023	SELL	$342.17 - $402.31 $1.9 Million - $2.23 Million	-5,539 Reduced 32.07%	11,733 $4.44 Million
Q3 2022 Nov 14, 2022	BUY	$343.2 - $395.75 $1.14 Million - $1.31 Million	3,318 Added 23.78%	17,272 $6.1 Million
Q2 2022 Aug 15, 2022	BUY	$269.58 - $378.88 $3.76 Million - $5.29 Million	13,954 New	13,954 $5.29 Million
Q1 2022 May 16, 2022	SELL	$254.45 - $351.06 $1.11 Million - $1.53 Million	-4,371 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$272.01 - $353.03 $856,559 - $1.11 Million	3,149 Added 257.69%	4,371 $1.53 Million
Q3 2021 Nov 15, 2021	SELL	$295.0 - $350.58 $37,465 - $44,523	-127 Reduced 9.41%	1,222 $369,000
Q2 2021 Aug 16, 2021	BUY	$257.11 - $319.92 $203,116 - $252,736	790 Added 141.32%	1,349 $406,000
Q1 2021 May 17, 2021	SELL	$268.3 - $380.31 $182,444 - $258,610	-680 Reduced 54.88%	559 $154,000
Q4 2020 Feb 16, 2021	SELL	$248.13 - $308.36 $447,130 - $555,664	-1,802 Reduced 59.26%	1,239 $364,000
Q3 2020 Nov 16, 2020	SELL	$215.51 - $272.51 $284,473 - $359,713	-1,320 Reduced 30.27%	3,041 $798,000
Q2 2020 Aug 14, 2020	SELL	$127.44 - $232.72 $167,711 - $306,259	-1,316 Reduced 23.18%	4,361 $982,000
Q1 2020 May 15, 2020	BUY	$108.83 - $165.23 $268,157 - $407,126	2,464 Added 76.69%	5,677 $748,000
Q4 2019 Feb 14, 2020	BUY	$106.59 - $164.21 $44,341 - $68,311	416 Added 14.87%	3,213 $516,000
Q3 2019 Nov 14, 2019	BUY	$113.31 - $150.51 $193,646 - $257,221	1,709 Added 157.08%	2,797 $319,000
Q2 2019 Aug 14, 2019	SELL	$115.0 - $141.58 $132,135 - $162,675	-1,149 Reduced 51.36%	1,088 $154,000
Q1 2019 May 15, 2019	SELL	$98.85 - $134.59 $79,574 - $108,344	-805 Reduced 26.46%	2,237 $279,000
Q4 2018 Feb 14, 2019	BUY	$63.81 - $109.82 $194,110 - $334,072	3,042 New	3,042 $292,000
Q3 2018 Nov 14, 2018	SELL	$75.5 - $96.63 $45,300 - $57,978	-600 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$74.84 - $100.16 $29,936 - $40,064	400 Added 200.0%	600 $50,000
Q1 2018 May 15, 2018	BUY	$56.95 - $85.19 $11,390 - $17,038	200 New	200 $16,000

Others Institutions Holding ARGX

# of Institutions

400

Shares Held

30.9M

Call Options Held

376K

Put Options Held

489K

Price T Rowe Associates Inc Baltimore, MD

5.82M
Shares

$3.28 Billion
0.36% of portfolio
Artisan Partners Limited Partnership Milwaukee, WI

3.51M
Shares

$1.98 Billion
2.99% of portfolio
Janus Henderson Group PLC London, X0

2.48M
Shares

$1.4 Billion
0.72% of portfolio
Capital World Investors Los Angeles, CA

1.7M
Shares

$959 Million
0.15% of portfolio
Avoro Capital Advisors LLC New York, NY

1.24M
Shares

$699 Million
10.11% of portfolio

View Full List

About ARGENX SE

Ticker ARGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,323,800
Market Cap $31.2B
Description
argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...

More about ARGX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.

Account